Bilal Murad, MD
Interventional Cardiology · Saint Paul, MNNPI 1922066901
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 22.8%.
Across 147 payments — averaging $114.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Edwards Lifesciences$4K
- Abbott$3K
- Shockwave Medical, Inc$2K
- Siemens Medical Solutions USA, Inc.$1K
- Corindus Inc.$1K
- plus $2K from 9 others
Across 53 payments — averaging $8413.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$446K
What the payments were for
- Consulting fees$2,81317%
- Speaking & faculty fees$1,80011%
- Travel & lodging$5,25131%
- Food & beverage$6,95441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $3,829 |
| Edwards Lifesciences | 62 | $3,780 |
| Abbott | 21 | $2,989 |
| Shockwave Medical, Inc | 7 | $1,975 |
| Siemens Medical Solutions USA, Inc. | 7 | $1,294 |
| Corindus Inc. | 6 | $1,287 |
| Abiomed | 17 | $567 |
| Medtronic | 3 | $442 |
| Cardiovascular Systems Inc. | 2 | $207 |
| ZOLL Circulation Inc | 2 | $194 |
| Teleflex LLC | 1 | $151 |
| Penumbra, Inc. | 1 | $45 |
| Heartflow, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVVIGO Guidance System$2,813
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,800
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,702
- CorPath Imaging System$1,172
- CorPath GRX$1,168
- COROFLOW$1,103
- DRAGONFLY OPSTAR$955
- GENERAL - THERAPIES$288
- Optis Coronary Imaging System$274
- Impella$242
- Ultreon$204
- COREVALVE EVOLUT R$189
- Diamondback Coronary$180
- PASCAL$169
- TherOx DS2 Console$167
- Catheter$167
- Downstream Cartridge$167
- Telescope$158
- ABSOLUTE PRO$154
- GUIDELINER$151
How this compares
$16,817 in reported general payments places this provider in the 70th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 130 | $147,089 |
| Repatha SureclickEvolocumab | 132 | $134,173 |
| XareltoRivaroxaban | 71 | $90,787 |
| JardianceEmpagliflozin | 80 | $81,147 |
| Praluent PenAlirocumab | 23 | $20,655 |
| Metoprolol Succinate | 402 | $7,209 |
| ClopidogrelClopidogrel Bisulfate | 376 | $5,675 |
| Atorvastatin Calcium | 253 | $3,119 |
| Rosuvastatin Calcium | 216 | $3,101 |
| Ranolazine ErRanolazine | 17 | $2,936 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 103 | $2,436 |
| Ezetimibe | 70 | $1,652 |
| Diltiazem 12hr ErDiltiazem Hcl | 11 | $1,610 |
| Losartan Potassium | 139 | $1,502 |
| Prasugrel Hcl | 18 | $1,405 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $147,089130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 84 interventional cardiology providers in Minnesota.
Other interventional cardiology in Saint Paul
- Brett OestreichSaint Paul$26K
- Marat YanavitskiSaint Paul$21K
- Jennifer RiggsSaint Paul$17K
- Kenneth BaranSaint Paul$16K
- Abdalla HassanSaint Paul$9K
- Marit ThorsgardSaint Paul$9K
- James KolbeckSaint Paul$5K
- Thom DahleSaint Cloud$1.1M
- Stephen KiddSaint Cloud$607K
- Brian StegmanSt Cloud$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.